Latest Operating Expenses News

Fluence Corporation Limited reported a solid cash flow position for Q3 2025, with positive net cash from operations and strong liquidity supported by available financing facilities.

BSP Financial Group has reported a robust third quarter for fiscal 2025, with revenue climbing 15% and net profit rising 22%, underpinned by strong operational discipline and strategic investments.

Nick Scali Limited reported a robust $62 million underlying profit for FY25, completed its UK acquisition equity raise, and announced key leadership changes as it eyes accelerated growth in FY26.

Everlast Minerals Ltd has successfully completed its IPO, raising $6 million and commencing ASX trading under ticker EV8, setting the stage for advancing its mineral sands projects in Bangladesh.

Temas Resources Corp. has successfully listed on the ASX, raising AU$11 million to advance its patented Regenerative Chloride Leach technology and strategic Québec titanium projects. The move aims to reshape Western critical metals supply chains with cost-effective, sustainable processing solutions.

Neurotech International has initiated an Authorised Prescriber program for its lead therapy NTI164, expanding access for children with neurodevelopmental disorders in Australia. The company also secured a Rare Pediatric Disease Designation from the US FDA for NTI164 in Rett Syndrome, marking a key regulatory milestone.

DigitalX Limited has enhanced its treasury strategy by investing nearly A$5 million into a market-neutral fund while increasing its Bitcoin holdings to over 500 BTC, aiming to balance accumulation with steady income generation.

Microba Life Sciences reports robust Q1 FY26 growth in microbiome diagnostics, introduces workflow-enhancing features, and prepares for key therapeutic deal catalysts by year-end.

Microba Life Sciences reports a 145% jump in core microbiome test volumes and is on track to achieve regional break-even by FY26, supported by strategic cost cuts and a $14.5 million capital raise.

AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy, advancing licensing negotiations for its first CAR-T product and raising $1.6 million through placements to bolster its financial position.

BetMakers Technology Group kicks off FY26 with a strong financial turnaround and strategic advances, including a promising acquisition and digital wagering expansion in Nevada.

BetMakers Technology Group has reported a remarkable 361% growth in adjusted EBITDA for Q1 FY26, driven by strong revenue gains and operational efficiencies, while advancing its strategic expansion into the Las Vegas racing market.